Skip to main content
Home
language-selector-globe Czech Republic | en
Choose Location
language-selector-globe Czech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Czech Republic
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in the Czech Republic 
      • Strategy 
      • Diversity and inclusion 
      • People and culture 
      • Products 
      • Country leadership team 
      • Our mission and vision 
      • Innovative medicines 
      • Contact 
      Novartis Česká republika About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Our patient portals for Czech Republic 
      • Products 
      • Adverse event reporting 
      • Provision of gifts and grants 
      Babička s vnučkou v objetí Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis pipeline 
      • Adverse event reporting 
      • Novartis clinical trials 
        • Clinical trials in Czech Republic 
      • VPOIS 
      • Expert information 
      Vědec se dívá do mikroskopu Healthcare Professionals
    • Research and development 
      • Research and development in Czech Republic 
      Vědkyně v laboratoři Research and development
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Ethical behavior 
      • Whistleblow line 
      Ruka na rozpukané vyprahlé hlíně ESG
    • News 
      • News archive 
      • Stories 
      • Media library 
      • Media contacts 
      Diskutující lidé s notebooky nad odbornými články News
    • Careers 
      • Career search 
      • Meet the teams 
      • Personal growth 
      • Early talent 
      • How we work 
      • Leadership trainee program 
      • Well-being 
      • Diversity and inclusion 
      • Awards and recognition 
      Usmívající se žena v posluchárně Careers
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu. Coronavirus
    Female scientist in laboratory Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort ascending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort ascending Business Functional Area Date Posted
(高级)医药代表 /(资深)产品专员 Xining (Qinghai Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
(高级)医药代表 /(资深)产品专员 Jinhua (Zhejiang Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Tianjin (Tianjin) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Zhenjiang (Jiangsu Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Qiqihar (Heilongjiang Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Shijiazhuang (Hebei Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Qingdao (Shandong Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Xining (Qinghai Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Yantai (Shandong Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 27, 2024
ERP Assurance Senior Consultant-2 INSURGENTES Mexico Finance CTS Audit & Finance Aug 20, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Aug 19, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Sep 13, 2024
Commercial & Medical Excellence Manager (f/m/d) Vienna Austria Finance Innovative Medicines Data and Digital Oct 15, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Oct 16, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 17, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Oct 17, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Sep 23, 2024
S2P Business Partner (Korean speaker) Selangor Malaysia Finance CTS Audit & Finance Sep 24, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Oct 02, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Oct 04, 2024
Long term Finance Internship İstanbul Kavacık Turkey Finance Innovative Medicines Others Sep 10, 2024
R2R Lead Israel Israel Israel Finance CTS Audit & Finance Sep 16, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit & Finance Sep 17, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Sep 17, 2024
Senior FRA Specialist GL Prague Czech Republic Finance CTS Audit & Finance Sep 26, 2024
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Sep 27, 2024
BPA & R2R Analyst Amsterdam Netherlands Finance Innovative Medicines Audit & Finance Sep 04, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Sep 05, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance Sep 06, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance May 31, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Jun 13, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance Jun 20, 2024
Senior Financial Reporting and Accounting Specialist Prague Czech Republic Finance CTS Audit & Finance Jul 03, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Jul 28, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Jul 22, 2024
P2P & T&E Specialist (Arabic Speaker) Selangor Malaysia Finance CTS Audit & Finance Jul 05, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 15, 2024
FRA Analyst Treasury and Cash Management / Analitik - specialist Ljubljana Slovenia Finance CTS Audit & Finance Oct 15, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 42
  • › Next page

Novartis Czech Republic

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
  • Adverse event reporting
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis websites
  • Global
Footer Bottom
© 2024 Novartis s.r.o
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Czech Republic